Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tochukwu C. Orjiakor"'
Autor:
Runcie C.W. Chidebe, Tochukwu C. Orjiakor, Nwamaka Lasebikan, Adedayo Joseph, Samantha Toland, Alison Simons
Publikováno v:
JCO Global Oncology, Vol , Iss 9 (2023)
PURPOSEA recent estimate indicates that Nigeria has about 70 clinical oncologists (COs) providing care for 124,815 patients with cancer and its 213 million total population. This staggering deficit is likely to worsen as about 90% of Nigerian physici
Externí odkaz:
https://doaj.org/article/acbc9be7371a4c0fa47ff3c51c701aec
Autor:
Simeon C. Aruah, Runcie C.W. Chidebe, Tochukwu C. Orjiakor, Fatima Uba, Uchechukwu N. Shagaya, Charles Ugwanyi, Aisha A. Umar, Taofeeq Ige, Obinna C. Asogwa, Oiza T. Ahmadu, Musa Ali-Gombe, Alabi Adewumi, Vitalis C. Okwor, Jimoh A. Mutiu, Basheer Bello, Lucy O. Eriba, Yusuf A. Ahmed, Awwal Bisalla, Ukamaka Itanyi, Ramatallah A. Balogun, Suleiman Alabi, David Pistenmaa, C. Norman Coleman, Dosanjh Manjit
Publikováno v:
JCO Global Oncology, Vol , Iss 9 (2023)
PURPOSEAccess to radiotherapy (RT) is now one of the stark examples of global cancer inequities. More than 800,000 new cancer cases require potentially curative or palliative RT services in Africa, arguably
Externí odkaz:
https://doaj.org/article/f26952229c9c4b3184b4eef35eeee8c2
Autor:
Runcie C W Chidebe, L Leigh Leibel, Tochukwu C Orjiakor, Ashish Shrestha, Agha A Agha, Duygu Altinok Dindar, Batuhan Kisakol, Sampson C Ipiankama, Ifeoma J Okoye, Malcolm Mason, Aviane Auguste, Darlingtina K Esiaka
Publikováno v:
The Lancet Oncology. 24:319-322
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db357729a9e6315bf8178d25da605359
https://doi.org/10.1016/s1470-2045(22)00692-1
https://doi.org/10.1016/s1470-2045(22)00692-1
Autor:
Runcie C. Chidebe, Theodora Nwosu-Zitta, Mary-Gloria A. Orji, Khadijat Banwo-Fatai, Agha A. Agha, Darlingtina K. Esiaka, Tochukwu C. Orjiakor
Publikováno v:
Cancer Research. 83:1982-1982
Background: Over 70% of breast cancer patients in Nigeria present metastatic/advanced breast cancer (MBC). An estimated 90% of breast cancer deaths are as a result of metastatic disease, either at diagnosis or recurrence. MBC is associated with sever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b7e47fd745b99b90625bcd80f21016a
https://doi.org/10.1158/1538-7445.am2023-1982
https://doi.org/10.1158/1538-7445.am2023-1982
Autor:
Runcie C. Chidebe, Ramatu M. Alabelewe, Darlingtina K. Esiaka, Gloria C. Okwu, Tochukwu C. Orjiakor, Nwamaka Lasebikan, Jacinta Emejulu, Adamu A. Umar, Ndifreke Okwuegbunam, Funsho David, Toyosi Adepoju, Krishna Prasad Sapkota, Candidus C. Nwakasi, Agha A. Agha, Simeon C. Aruah, Katy Graef, Richard Mshelia, Rob Duncombe, Matthew O. Nwaneri, Noel Wannang, Cindy O’Bryant, R. Donald Harvey, Peace C. Babalola, Folakemi T. Odedina
Publikováno v:
Cancer Research. 83:723-723
BackgroundNigeria has the highest cancer burden in Africa with 124,815 cancer cases and 78,899 cancer deaths in 2020. The limited number of oncology specialists, inaccessibility of essential cancer medicines like chemotherapies, and suboptimal delive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::608fa7cf3b5eea46814f76a8d48953de
https://doi.org/10.1158/1538-7445.am2023-723
https://doi.org/10.1158/1538-7445.am2023-723